FdaApplication

NDA 013416

Back to search

Identifiers

Properties

PropertyValue
applicant_nameBAUSCH HEALTH US LLC
application_typeNDA
approval_date1982-10-27

Products (2)

ProductActive ingredientStrengthDosage form
NORGESICASPIRIN; CAFFEINE; ORPHENADRINE CITRATE385MG;30MG;25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**TABLET;ORAL
NORGESIC FORTEASPIRIN; CAFFEINE; ORPHENADRINE CITRATE770MG;60MG;50MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**TABLET;ORAL

2 products